toripalimab
junshi biosciences,coherus
['neotorch', 'toripalimab', 'nsclc', 'sclc']
another neo io trial for nsclc. toripalimab . neotorch trial . why efs is much more in squamous histology ? any specific reasons? os is stil not mature. #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists